Typhoid vaccine - Matrivax
Alternative Names: Typhax; Typhax - Matrivax; Vi PCMV; Vi PCMV - MatrivaxLatest Information Update: 13 Jul 2023
At a glance
- Originator Matrivax
- Class Bacterial polysaccharides; Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase I Typhoid
Most Recent Events
- 12 Jul 2023 Typhoid vaccine - Matrivax is still in phase I trials for Typhoid (Prevention) in USA (IM) (Matrivax pipeline, July 2023)
- 28 Dec 2020 No recent reports of development identified for phase-I development in Typhoid(Prevention) in USA (IM)
- 30 Apr 2019 Typhoid vaccine - Matrivax is available for licensing as of 30 Apr 2019. http://www.matrivax.com/